David Middlemiss | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where David Middlemiss is active.

Explore More

Publication

Featured researches published by David Middlemiss.

Archive | 2004

Use of crth2 antagonist compounds in therapy

Mark Richard Ashton; Edward Andrew Boyd; Frederick Arthur Brookfield; Mick Hunter; David Middlemiss; Christopher Palmer; Eric Roy Pettipher; Mark Whittaker

Journal of Medicinal Chemistry | 2005

Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2

Richard Edward Armer; Mark Richard Ashton; Edward Andrew Boyd; Chris J. Brennan; Frederick Arthur Brookfield; Lucien Gazi; Shan L. Gyles; Philip Andrew Hay; Michael George Hunter; David Middlemiss; Mark Whittaker; Luzheng Xue; Roy Pettipher

Archive | 2004

Compounds with pgd2 antagonist activity

David Middlemiss; Mark Richard Ashton; Edward Andrew Boyd; Frederick Arthur Brookfield; Richard Edward Armer; Eric Roy Pettipher

Archive | 2003

Substituted indol-3-yl acetic acid derivatives

Mark Richard Ashton; Edward Andrew Boyd; Frederick Arthur Brookfield; David Middlemiss

Archive | 2008

Treatment of CRTH2-mediated diseases and conditions

David Middlemiss; Mark Richard Ashton; Edward Andrew Boyd; Frederick Arthur Brookfield; Michael George Hunter; Mark Whittaker; Christopher Palmer; Eric Roy Pettipher

Archive | 2004

Compounds for the treatment of CRTH2-mediated diseases and conditions

David Middlemiss; Mark Richard Ashton; Edward Andrew Boyd; Frederick Arthur Brookfield; Eric Roy Pettipher; Michael George Hunter; Mark Whittaker; Christopher Palmer

Journal of Medicinal Chemistry | 1983

Synthesis of exo-3-phenylbicyclo[3.2.1]oct-3-en-2-amine and related compounds as potential analgesics.

Alan Richard Harris; David Middlemiss; Keith Mills; Alma J. Gower; Michael B. Tyers

Archive | 2004

Anvendelse af CRTH2-antagonistforbindelser i terapi

David Middlemiss; Mark Richard Ashton; Edward Andrew Boyd; Frederick Arthur Brookfield; Eric Roy Pettipher; Mark Whittaker; Christopher Palmer; Mick Hunter

Archive | 2004

Composes presentant une activite antagoniste de crth2

David Middlemiss; Mark Richard Ashton; Edward Boyd; Frederick Arthur Brookfield; Richard Edward Armer; Eric Roy Pettipher

Archive | 2004

Verwendung von crth2-antagonisten-verbindungen in der therapie

David Middlemiss; Mark Richard Ashton; Edward Andrew Boyd; Frederick Arthur Brookfield; Eric Roy Pettipher; Mark Whittaker; Christopher Palmer; Mick Hunter

Explore More